Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
42
INTT Quote, Financials, Valuation and Earnings
Last price:
$7.51
Seasonality move
:
11.1%
Day range:
$7.64 - $7.96
52-week range:
$6.28 - $14.35
Dividend yield:
0%
P/E ratio:
33.65x
P/S ratio:
0.72x
P/B ratio:
0.96x
Volume:
24.3K
Avg. volume:
47.6K
1-year change:
-31.08%
Market cap:
$95.8M
Revenue:
$130.7M
EPS (TTM):
$0.23
INTT Analysts' Consensus Rating
The 3 analysts providing 12-month price projections for inTest shares anticipate an average target of $12.67, ranging from a low estimate of $10.00 to a high estimate of $15.00. This average target implies a growth of 63.65% compared to the current stock price of $7.74.
Consensus Price Target
$12.67
Highest Price Target
$15.00
Lowest Price Target
$10.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 0 | 3 |
| Hold | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | -- | Buy |
INTT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
